e-Article
Successful treatment with rituximab and donor lymphocyte infusions for fulminant EBV-associated lymphoproliferative disorder that developed 14 years after unrelated BMT.
Document Type
Letter
Author
Source
Subject
*LETTERS to the editor
*EPSTEIN-Barr virus
*LYMPHOPROLIFERATIVE disorders
*
*
Language
ISSN
0268-3369
Abstract
A letter to the editor is presented regarding successful treatment for fulminant Epstein-Barr virus (EBV)-associated lymphoproliferative disorder with rituximab and donor lymphocyte infusions.